Post-marketing Surveillance of Ventilat® in Long-term Therapy in Chronic Obstructive Pulmonary Disease

Boehringer Ingelheim

Status: Completed

Conditions: Pulmonary Disease, Chronic Obstructive

Treatments: Drug: Ventilat® - metered dose inhaler

Study type: Observational

Funder types: Industry

Identifiers

NCT02233907

54.563

Details and patient eligibility

About

Study to obtain further information on the tolerability and efficacy of Ventilat® metered dose inhaler in long-term treatment of Chronic Obstructive Pulmonary Disease under conditions of daily practice

Enrollment: 595 patients

Sex: All

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients of both genders older than 40 years, who suffer from Chronic Obstructive Pulmonary Disease
• Only patients who have not been treated with Ventilat® within the last year are to be considered for inclusion

Exclusion criteria

• Contraindications listed in the Instructions for Use/Summary of Product Characteristics for Ventilat® metered dose inhaler

Trial design

595 participants in 1 patient group

Chronic obstructive pulmonary disease patients

Treatment:

Drug: Ventilat® - metered dose inhaler